Clinical Trials Logo

Vogt Koyanagi Harada Disease clinical trials

View clinical trials related to Vogt Koyanagi Harada Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT05627739 Recruiting - Clinical trials for Mycophenolate Mofetil

A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease

Start date: October 1, 2021
Phase:
Study type: Observational

This project is designed to test the hypothesis that Mycophenolate Mofetil is clinically useful for patients with relapse Vogt-Koyanagi-Harada disease

NCT ID: NCT05590416 Recruiting - Adalimumab Clinical Trials

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

Start date: June 1, 2021
Phase:
Study type: Observational

This project is designed to test the hypothesis that adalimumab is clinically useful for patients with acuta Vogt-Koyanagi-Harada disease

NCT ID: NCT05496530 Recruiting - Clinical trials for Diabetic Macular Edema

Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

Start date: July 10, 2022
Phase: N/A
Study type: Interventional

Suprachoroidal drug delivery is a recent route for managing various ocular conditions. Safety and long term results are still under investigations.

NCT ID: NCT05031143 Completed - Clinical trials for Vogt Koyanagi Harada Disease

Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

Start date: April 1, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Suprachoroidal injection, a novel technique for delivering ocular therapies, may facilitate targeted therapeutic delivery to the choroidal and retinal structures than intravitreal injection

NCT ID: NCT04126850 Not yet recruiting - Behçet Disease Clinical Trials

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease

Start date: November 1, 2019
Phase:
Study type: Observational

This study aimed to discover the composition on the microbiome in several sites of the human body; and to find out the difference in microbiome composition on ocular fluid, blood, and feces before and after therapy in uveitis patient with history of autoimmune disease (Behcet and Vogt-Koyanagi-Harada) and idiopathic uveitis

NCT ID: NCT03399175 Recruiting - Clinical trials for Vogt Koyanagi Harada Disease

Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

Start date: March 23, 2015
Phase: N/A
Study type: Interventional

This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.

NCT ID: NCT00407121 Withdrawn - Clinical trials for Vogt Koyanagi Harada Disease

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Start date: December 2006
Phase: Phase 3
Study type: Interventional

Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.